The PEDAP trial. The Pediatric Artificial Pancreas (PEDAP) clinical trial was conducted to compare the efficacy and safety of closed-loop insulin delivery with standard care in children with type 1… Continue reading Closed-loop insulin pump for children ages 2-6
The automated insulin pump has already shown great results in type 1 diabetes in an ambulatory setting. This study shows that it is as useful in type 2 diabetes patients treated in the hospital. Patients utilizing the “artificial pancreas” had better glycemic control, without an increased risk of hypoglycemia. I anticipate that closed-loop, automated insulin devices will become the “standard of care” for hospitalized patients with type 1 and type 2 diabetes in the future.
The study reveals that the hybrid closed loop device, MiniMed 670g, helps in reducing A1c by 0.75% compared to standard insulin pumps. For those transitioning to it, carbohydrate to insulin ratio needs to be adjusted immediately. This semi-automated system, differently called semi-artificial pancreas, is a significant advancement in the field of type 1 diabetes. The device was approved by FDA in September 2016.
FreeStyle Libre is the first glucometer without the use of fingersticks for measurements or calibration. It received the FDA approval in September 2017. Below is a nice video on how to apply the sensor and use the scanner.